Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic and Pharmacodynamic Study of VI-0521 in Obese Adolescents
Conditions
Interventions
Placebo
VI-0521 Mid Dose
+1 more
Locations
4
United States
Research Facility
Baton Rouge, Louisiana, United States
Research Facility
Marrero, Louisiana, United States
Research Facility
Cincinnati, Ohio, United States
Research Facility
Charleston, South Carolina, United States
Start Date
March 1, 2016
Primary Completion Date
October 1, 2016
Completion Date
November 1, 2016
Last Updated
August 23, 2022
NCT04036331
NCT06116422
NCT06888011
NCT07185789
NCT05945355
NCT03514602
Lead Sponsor
VIVUS LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions